Table 3. RAS mutations and other... | American Society of Hematology

Table 3.

RAS mutations and other recurrent genetic alterations in MM

	Cyclin D1 (%)	FGFR3/MMSET^*(%)	Negative†(%)
RAS mutation, n = 17	11/17 (65)	0/17 (0)	6/17 (35)
No RAS mutation, n = 37	11/37 (30)	7/37 (19)	19/37 (51)
P	.015	.055	.272

	Cyclin D1 (%)	FGFR3/MMSET^*(%)	Negative†(%)
RAS mutation, n = 17	11/17 (65)	0/17 (0)	6/17 (35)
No RAS mutation, n = 37	11/37 (30)	7/37 (19)	19/37 (51)
P	.015	.055	.272

Translocation t(4;14) identified by both IGH-MMSET and FGFR3/MMSET expression (see “Patients, materials, and methods”).

PCs without a detectable cyclin D1, FGFR3, MMSET, or IGH-MMSET expression.